Lifeline Scientific, Inc Posting of Annual Report & Notice of AGM (0619Z)

TIDMLSIC

RNS Number : 0619Z

Lifeline Scientific, Inc

24 May 2016

Lifeline Scientific, Inc.

("Lifeline" or the "Company")

Posting of Annual Report & Notice of AGM

Lifeline Scientific (AIM: LSIC), the transplantation technology company, confirms that the Annual Report and Accounts for the year ended 31 December 2015 ('2015 Annual Report and Accounts'), the Notice of Annual General Meeting ('AGM') and a Form of Proxy were posted to shareholders on 20 May 2016.

The AGM is to be held at 8.30am US CDT on 23 June 2016 at the Westin Hotel, 400 Park Boulevard, Itasca, IL 60143, USA.

A copy of the 2015 Annual Report and Accounts is available on the Company's website: www.lifeline-scientific.com

For further information:

 
 Lifeline Scientific, Inc.                              www.lifeline-scientific.com 
 David Kravitz, CEO                                            Tel: [phone] 
 Lisa Kieres, CFO                                              Tel: [phone] 
 
 Panmure Gordon (UK) Limited                               Tel: [phone] 
 Freddy Crossley (Corporate 
  Finance) 
 Tom Salvesen (Corporate 
  Broking) 
 
 Walbrook PR Limited           Tel: [phone] or [e-mail] 
 Lianne Cawthorne                                          Mob: [phone] 
 Mike Wort                                                 Mob: [phone] 
 

About Lifeline Scientific Inc.

Lifeline Scientific, Inc. is a Chicago-based global medical technology company with regional offices in Brussels and Sao Paulo. The Company's focus is the development of innovative products that improve transplant outcomes and lower the overall costs of transplantation. Its lead product, LifePort Kidney Transporter, is the global market-leading medical device for hypothermic machine preservation of donor kidneys. LifePorts and novel solutions designed for preservation of other organs are in development, with LifePort Liver Transporter next in line for commercial launch. For more information please visit www.lifeline-scientific.com

About LifePort Kidney Transporter

Created with the challenges of organ recovery and transport in mind, LifePort Kidney Transporter is a proprietary medical device designed to help improve kidney preservation, evaluation and transport prior to transplantation. It has been widely studied in clinical trials throughout the world and is the standard of care for machine preservation of donor kidneys. Employed by surgeons in over 206 leading transplant programmes in 29 countries, LifePorts have successfully preserved more than 70,000 kidneys indicated for clinical transplant. For more information please visit www.organ-recovery.com

About LifePort Liver Transporter

LifePort Liver Transporter is modelled upon the clinically proven technology platform of LifePort Kidney Transporter and the Company's early HMP prototype successfully used in clinical transplant studies by surgeons at New York-Presbyterian Hospital/Columbia University Medical Center. LifePort Liver Transporter and the Company's proprietary machine preservation solution, Vasosol(R), are in the process of US and international regulatory registrations. The system is designed to help improve outcomes in liver transplantation by enabling the clinical use of hypothermic machine perfusion, and has been developed in consultation with clinical and research teams specialising in liver transplantation at Columbia University Medical Center and the University of Chicago. The system employs a rugged, streamlined ergonomic design for ease of use and transportability from donor bedside to recipient operating room. For more information please visit: http://www.organ-recovery.com/pipeline.php

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCEAXSDAELKEFF

(END) Dow Jones Newswires

May 24, 2016 02:00 ET (06:00 GMT)